Ambr 250 or Equal High Throughput Bioreactor System for NIAID VPP
ID: SS-NIAID-24-2220774Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/8ad4ca84034844c38fabb0cecefb1407/view
Timeline
    Description

    Sources Sought HEALTH AND HUMAN SERVICES, DEPARTMENT OF Ambr 250 or Equal High Throughput Bioreactor System for NIAID VPP

    The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC), Vaccine Production Program (VPP) is seeking to acquire two (2) Brand Name Sartorius Ambr 250 high-throughput bioreactor systems for its Cell Culture Development (CCD) team for mammalian cell culture clone and growth condition screening processes. This acquisition ensures CCD has a suite of reliable small-scale bioreactors capable of broad screening that will prevent bottlenecks and delays to work.

    The high-throughput bioreactor systems must meet specific technical requirements, including being high throughput, 24-way, scale-down model designed for process development. They must also have specific dimensions, electrical requirements, and the ability to support various supplies and processes. Additionally, the systems must be compatible with specific consumables and have features such as automated sampling, control software, and SCADA integration.

    The anticipated period of performance is on or about September 27, 2024, with delivery required within 65 days upon award.

    Interested organizations are invited to submit a response to this Sources Sought Notice by August 5, 2024, at 3:00 PM EST. The response should include organization information, capability statement, place of manufacture, evidence of authorization, and information on sustainability practices.

    Please submit responses to Kathy Song at kathy.song@nih.gov.

    Note: This notice does not obligate the Government to award a contract or provide payment for the information provided. The Government reserves the right to use the information for any necessary and appropriate purpose.

    Point(s) of Contact
    Kathy Song
    kathy.song@nih.gov
    Linda Smith
    linda.smith2@nih.gov
    Lifecycle
    Title
    Type
    Ambr 250 or Equal High Throughput Bioreactor System for NIAID VPP
    Currently viewing
    Sources Sought
    Similar Opportunities
    Automated Liquid Handling Systems– Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of two automated liquid handling systems, either brand name or equal, to support the Vaccine Production Program (VPP) at the National Institute of Allergy and Infectious Diseases (NIAID). These systems are critical for high-throughput, microscale protein purification and product characterization, which are essential for developing vaccines against various pathogens, including HIV and SARS-COV-2. Interested vendors must submit their quotes by 12:00 PM EST on September 23, 2024, to Daveta H. Brown at daveta.brown@nih.gov, ensuring compliance with all specified requirements and regulations outlined in the solicitation documents.
    Alto Instrument with Nicosystem Pro - Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotations for the procurement of two biolayer interferometer instruments, either brand name or equal, to support monoclonal antibody and vaccine development projects at its Vaccine Research Center. The instruments must meet specific technical requirements, including high-throughput capabilities, integration with existing liquid handling systems, and user-friendly analysis software, to facilitate the efficient quantification of proteins and other biological samples. Interested vendors must submit their quotes by September 17, 2024, with delivery expected within 30 days post-award, and are required to be registered in the System for Award Management (SAM). For further inquiries, vendors can contact Hershea Vance at hershea.vance@nih.gov or Linda Smith at linda.smith2@nih.gov.
    Next-Generation Sequencing (NGS) Liquid Handling Systems – Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for two Next-Generation Sequencing (NGS) Liquid Handling Systems to enhance research capabilities at its Bethesda, Maryland campus. These systems are essential for high-throughput processing in infectious disease research, particularly for single cell-based antibody discovery and RNA/DNA processing, which are critical for pandemic preparedness. Interested vendors must submit their quotes by 12:00 pm EST on September 26, 2024, including detailed specifications and compliance with federal regulations, to Daveta H. Brown at daveta.brown@nih.gov.
    Surface Plasmon Resonance (SPR) Instrument- Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for a Surface Plasmon Resonance (SPR) Instrument, either brand name or equal, to support its Vaccine Research Center's structural biology efforts. The procurement aims to acquire a high-throughput SPR instrument that meets specific technical requirements, including dimensions, weight, temperature ranges, and data collection capabilities, to facilitate biophysical and structural analysis of macromolecules. This equipment is critical for advancing research in infectious diseases and vaccine development. Interested vendors must submit their quotes by 4:30 PM EST on September 19, 2024, to Hershea Vance at hershea.vance@nih.gov, and ensure compliance with all specified requirements and clauses outlined in the solicitation documents.
    BD FACS Symphony S6 Cell Sorter (Brand Name or Equal)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to procure one (1) BD FACSymphony S6 SE Cell Sorter System (or equal) along with a twelve-month maintenance agreement for parts and labor. This procurement is critical as the existing cell sorter is nearing the end of its life cycle, and the new system must meet specific requirements, including compatibility with FlowJo software and advanced operational safety features, to support high-containment research involving infectious samples. Interested vendors are required to submit comprehensive quotes by September 19, 2024, with evaluations focusing on technical acceptability, past performance, and price to ensure the best value for the government. For further inquiries, vendors can contact Linda Smith at linda.smith2@nih.gov or Christian Brown at christian.brown@nih.gov.
    Qiagen Real Time Semi-Quantitative PCR (RT-qPCR) and Digital PCR (dPCR) System or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for a Qiagen Real Time Semi-Quantitative PCR (RT-qPCR) and Digital PCR (dPCR) System or an equivalent product. The procurement aims to support research into neurodegenerative diseases and retroviral infections, requiring a system with multiplex capability for detecting five gene targets, automated operation, low variability in results, and a compact size not exceeding 16” x 28” x 20”. Proposals must be submitted by 9:00 a.m. Eastern Time on September 17, 2024, and should include a completed copy of certain FAR clauses and the Unique Entity ID. For further inquiries, interested parties can contact Frederick Weddington at frederick.weddington@nih.gov or by phone at 301-594-6835.
    Brand Name or Equal: Attana automated sample-robot for Attana Cell 200/250 System
    Active
    Health And Human Services, Department Of
    Sources Sought HEALTH AND HUMAN SERVICES, DEPARTMENT OF NATIONAL INSTITUTES OF HEALTH is seeking a brand name or equal Attana automated sample-robot for Attana Cell 200/250 System. This laboratory equipment and supplies procurement is for the Mass Spectrometry and Epitope Discovery Facility (MSEDF) at the Center for Immuno-Oncology (CIO), Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH). The facility requires an upgraded version of the existing Attana 200 Cell system's automated robot component for sample storage, handling, rinsing, and injection into the Attana 200 Cell system for analysis. The new system must be fully compatible and seamlessly integrate with the existing system, conduct all workflow steps autonomously, produce consistent and repeatable workflows, have a temperature-controlled sample storage unit, and be supported by software compatible with the Attana 200 Cell system. The procurement includes the Attana upgrade: automated sample-robot for Cell 200/250, Attana sample storage, cooled, and Attana software upgrade for new automation. Delivery and installation are required within fourteen (14) calendar days of the purchase order award at Bldg. 10, 10 Center Dr., Bethesda, MD 20892. The contractor must provide one (1) training session for NCI staff at the location of delivery within two (2) business days of equipment installation.
    Mass Spectrometer
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotations for a Brand Name or Equal Bruker Daltonics Mass Spectrometer Model timsTOF flex to replace a decommissioned unit within its Vaccine Production Program (VPP). This procurement is critical for maintaining and enhancing mass spectrometry capabilities that support vaccine development against infectious diseases such as HIV, Ebola, and Zika, particularly in light of recent global health challenges. The selected vendor must deliver the equipment within 30 days of contract award, and quotes are due by September 19, 2024. Interested vendors should direct inquiries to Uju Obii-Obioha at uju.obii-obioha@nih.gov or Linda Smith at linda.smith2@nih.gov for further information.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Good Manufacturing Practice (GMP)-manufactured Monoclonal Antibody
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to award a sole source contract for the procurement of Good Manufacturing Practice (GMP)-manufactured Monoclonal Antibody UB-421, with a requirement of 100 liters. This procurement is critical for an ongoing clinical trial aimed at treating patients with multidrug-resistant HIV-1 infection, utilizing UB-421, which is exclusively manufactured by United BioPharma, Inc., the sole patent holder and provider of the necessary cell line for production. Interested parties who believe they can meet the specifications must submit a capability statement to the primary contact, Hershea Vance, by 3:00 PM EST on September 20, 2024, as the contract is expected to be awarded within 19 days of this notice, with a performance period from September 23, 2024, to September 24, 2025.